The Year in Parkinson’s Disease 2024 - Medscape
20 hours ago · Drs Indu Subramanian and Alfonso Fasano discuss some of the 2024 highlights in Parkinson’s disease research, including a paradigm shift in diagnosis and the potential role of GLP-1s.
HHS Announces Progress on Establishing the National Parkinson's …
2 days ago · Today, U.S. Department of Health and Human Services Secretary Xavier Becerra announced he would delegate the authority vested in the HHS under the Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act to the National Institutes of Health, with support from the HHS Office of the Assistant Secretary for Health.
Parkinson's News Today Home | Parkinson's News Today
5 days ago · New tool could show how genetic variants raise Parkinson’s risk. A new screening method may shed light on the interactions between genetic variants that increase the risk of Parkinson’s disease, providing potential avenues for improving risk prediction and personalized care, a study found.
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...
Top Parkinson’s Science News Articles of 2024
Dec 10, 2024 · Our Science News article series highlight exciting Parkinson’s studies and how they impact those living with this disease. Explore our top Science News articles of 2024 below: 1. A Skin Test Could Detect Parkinson’s and Related Diseases.
Parkinson's News -- ScienceDaily
2 days ago · Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
Parkinson's disease - Latest research and news | Nature
2 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
Risvodetinib may slow Parkinson's progression, clinical trial...
Mar 11, 2024 · Risvodetinib, an oral therapy being developed by Inhibikase Therapeutics for Parkinson’s disease, appears to stabilize disease status and severity, according to data covering 25 patients who finished 12 weeks of dosing in an ongoing Phase 2 clinical trial.
New Vaccine for Parkinson’s Moves Closer to 1st Human Trials
Dec 1, 2022 · An experimental vaccine that stimulates immune responses against three regions of the alpha-synuclein protein — whose toxic clumps contribute to Parkinson’s disease and dementia with Lewy bodies (DLB) — is moving into late-stage preclinical research aimed at supporting future requests to test it in clinical trials.
New Findings About Key Pathological Protein in Parkinson’s Disease …
Dec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.